Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 4, 1996, Pages 243-247

  Gattorno, Marco ^a   Picco, Paolo ^a   Buoncompagni, Antonella ^a   Stalla, Franca ^b   Facchetti, Paola ^c   Sormani, Maria Pia ^d   Pistoia, Vito ^c  

^a G GASLINI INSTITUTE   (Italy)

^b Blood Transfusion Centre

^c Laboratory of Oncology

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRIORITY JOURNAL; SYNOVIAL FLUID;

EID: 0029875374     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.4.243     Document Type: Article

References (21)

1. Brennan F M, Maini R N, Feldmann M. TNF-α: a pivotal role in rheumatoid arthritis? Br J Rheumatol 1992; 31: 293-8.
2. Williams R O, Feldmann M, Maini R N. Anti-rumour necrosis factor ameliorates joint disease in murine collagen induced arthritis. Proc Natl Acad Sci USA 1992; 89: 9784-8.
3. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4025-31.
4. Eliott M J, Maini R M, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor-α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-10.
5. Prieur M, Kaufman M T, Griscelli C, Dayer J M. Specific interleukin 1 inhibitor in serum and urine of children with systemic JCA. Lancet 1987; 2: 1240-2.
6. De Benedetti F, Massa M, Robbioni P, Burgio G R, Martini A. Correlation of serum interleukin 6 levels with joint involvement and thromocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34: 1158-63.
7. Woo P. Cytokines in childhood rheumatic diseases. Arch Dis Child 1993; 69: 547-9.
8. Madson K L, Moore T L, Lawrence J M III, Osborn T G. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994; 21: 2359-63.
9. Lepore L, Pennesi M, Saletta S, Pertecarari S, Presani G, Prodon M. Study of IL-2, IL-6, TNF-α, INF-γ and β in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994; 12: 561-6.
10. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991; 285: 199-212.
11. Southwood T R, Malleson P N. The clinical history and physical examination. In: Southwood T R, Malleson P N, eds. Arthritis in children and adolescents. Clinical Paediatrics, vol 3. London: Bailliere Tindall, 1993; 637-64.
12. Grau G E. The influence of soluble receptors in cytokine measurement. J NIH Res 1995; 7: 82.
13. Brockhaus M, Schoenfeld D J, Schlaeger E J, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127-31.
14. Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammatory parameters and clinical subtypes. Arthritis Rheum 1995; 38: 211-20.
15. Cope A P, Maini R N. Soluble tumor necrosis factor receptors in arthritis. J Rheumatol 1995; 22: 382-4.
16. Brennan F M, Cope A P, Katsikis P, Gibbons D L, Maini R N, Feldmann M. Selective immunosuppression of tumor necrosis factor-alpha in rheumatoid arthritis. In: L Adorini, ed. Selective immunosuppression: basic concepts and clincal applications (Chem Immunol), vol 60. Basel: Karger, 1995; 48-60.
17. Cope A P, Aderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992; 35: 1160-9.
18. Roux-Lombard P, Punzi L, Hasler F, et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluid. Arthritis Rheum 1993; 36: 485-9.
19. Cope A P, Aderka D, Wallach D, et al. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 1995; 84: 21-30.
20. Higuchi M, Aggarwaal B B. TNF induces internalization of p60 receptor and shedding of the p80 receptor. J Immunol 1994; 152: 3550-8.
21. Brennan F M, Gibbons D L, Mitchell T, Cope A P, Maini R N, Feldmann M. Enhanced expression of tumor necrosis factor receptors mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol 1992; 22: 1907-12.